National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013 (No. 8) (No. PB 39 of 2013) (Cth)

PB 39 of 2013

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013
(No. 8)

National Health Act 1953

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 99AEH of the National Health Act 1953.

Dated    18 June 2013

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

1          Name of Instrument

(1)        This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013 (No. 8).

(2)        This Instrument may also be cited as PB 39 of 2013.

2          Commencement

This Instrument commences on 1 July 2013.

3          Amendment of National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)

Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012).

Schedule 1     Amendments

1. Schedule 1, entry for Rosuvastatin in the form Tablet 5 mg (as calcium)

(a)omit:

Cavstat	AF	MP	C1540 C3047 C4225 C4228	P1540 P4228	30	5	30
NP	C1540 C4228	30	5	30

(b)omit:

Rosuvastatin GH	GQ	MP	C1540 C3047 C4225 C4228	P1540 P4228	30	5	30
NP	C1540 C4228	30	5	30

(c)omit:

Cavstat AF MP C1540 C3047 C4225 C4228 P3047 P4225 30 11 30

(d)omit:

Rosuvastatin GH GQ MP C1540 C3047 C4225 C4228 P3047 P4225 30 11 30

1. Schedule 1, entry for Rosuvastatin in the form Tablet 10 mg (as calcium)

(a)omit:

Cavstat	AF	MP	C1540 C3047 C4225 C4228	P1540 P4228	30	5	30
NP	C1540 C4228	30	5	30

(b)omit:

Rosuvastatin GH	GQ	MP	C1540 C3047 C4225 C4228	P1540 P4228	30	5	30
NP	C1540 C4228	30	5	30

(c)omit:

Cavstat AF MP C1540 C3047 C4225 C4228 P3047 P4225 30 11 30

(d)omit:

Rosuvastatin GH GQ MP C1540 C3047 C4225 C4228 P3047 P4225 30 11 30

1. Schedule 1, entry for Rosuvastatin in the form Tablet 20 mg (as calcium)

(a)omit:

Cavstat	AF	MP	C1540 C3047 C4225 C4227	P1540 P4227	30	5	30
NP	C1540 C4227	30	5	30

(b)omit:

Rosuvastatin GH	GQ	MP	C1540 C3047 C4225 C4227	P1540 P4227	30	5	30
NP	C1540 C4227	30	5	30

(c)omit:

Cavstat AF MP C1540 C3047 C4225 C4227 P3047 P4225 30 11 30

(d)omit:

Rosuvastatin GH GQ MP C1540 C3047 C4225 C4227 P3047 P4225 30 11 30

1. Schedule 1, entry for Rosuvastatin in the form Tablet 40 mg (as calcium)

(a)omit:

Cavstat	AF	MP	C1540 C3047 C4225 C4226	P1540 P4226	30	5	30
NP	C1540 C4226	30	5	30

(b)omit:

Rosuvastatin GH	GQ	MP	C1540 C3047 C4225 C4226	P1540 P4226	30	5	30
NP	C1540 C4226	30	5	30

(c)omit:

Cavstat AF MP C1540 C3047 C4225 C4226 P3047 P4225 30 11 30

(d)omit:

Rosuvastatin GH GQ MP C1540 C3047 C4225 C4226 P3047 P4225 30 11 30

^{­­­­­­­­­­­­}